Papers
17
Total Citations
517
H-Index
10
About
Bruce L. Jacobs is a leading urologic oncologist and health services researcher whose work sits at the intersection of surgical innovation, health policy, and patient-centered outcomes. His research primarily focuses on the diffusion and impact of advanced technologies—particularly robotic surgery and intensity-modulated radiotherapy—in the treatment of prostate and bladder cancers. Jacobs is best known for his landmark study showing that many men at low risk of dying from prostate cancer nonetheless receive advanced, costly treatments (141 citations), a finding that has shaped clinical guidelines and sparked debate on overtreatment. He has also produced influential work on the cost-effectiveness of robotic-assisted procedures, the role of nerve growth factor as a urinary biomarker, and the influence of state certificate-of-need laws on technology adoption. With over 400 citations across his most-cited papers, Jacobs’ research consistently demonstrates how technological diffusion can drive both benefits and unintended consequences in urologic care. His work is essential reading for anyone interested in how surgical robots reshape practice patterns, healthcare costs, and patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Diffusion and adoption of the surgical robot in urology38 citations · 2021
- 5
- 6Understanding Criteria for Surveillance of Patients With a Small Renal Mass30 citations · 2012
- 7
- 8
- 9The Impact of Technology Diffusion on Treatment for Prostate Cancer15 citations · 2013
- 10Technology Diffusion and Diagnostic Testing for Prostate Cancer13 citations · 2013